Victoria Clinical Research Clinical Trials

06/03/2026

🫁 Now Enrolling: Asthma Research Studies

Do you or a loved one live with asthma?
You may qualify to participate in a clinical research study aimed at advancing asthma care.

You may be eligible if you:
✔️ Are between the ages of 12 - 80
✔️ Have been diagnosed with asthma
✔️ Are prescribed a daily ("maintenance") inhaler
💰 Compensation up to $1,500 may be available for qualified participants.

📩 Message us today to learn more or enroll!

05/20/2026

🌿 May is Asthma & Allergy Awareness Month 🌿

Victoria Clinical Research Group is currently enrolling for asthma studies focused on improving care for individuals living with asthma.

You may qualify if you:
Are between the ages of 12 - 80
Have a diagnosis of asthma
Are prescribed a daily (“maintenance”) inhaler

💰 Compensation up to $1,500 available for qualified participants.

📩 Message us today to learn more or enroll!

05/08/2026

Now Enrolling: MMRV Study (Counts toward school vaccine requirement)

Ages: Children aged 4 up to 6 years and 364 days

✔️Must have received the first dose of a Varicella vaccine
✔️Must have received the first dose of an MMR vaccine
📅Vaccines must have been given between 12 and 24 months of age
🎁Compensation available for qualified participants

📩Message us today to learn more!

04/28/2026

📣 Now Enrolling: COPD Clinical Study

Victoria Clinical Research Group is currently looking for participants.
You may be eligible if you:
👤 Are 40–80 years old
🚬 Are you a current or former smoker/vaper
🩺 Have been diagnosed with COPD
💰 Compensation for time/travel for qualified participants

📩 Send us a message today to get started.

Chronic Obstructive Pulmonary Disease, or COPD, is a disease that makes it harder to breathe. COPD is also known as chronic bronchitis or emphysema. Learn ab...

04/22/2026

📣 VCRG is Now Enrolling: Pneumococcal Vaccine Study
Clinical research study focused on pneumococcal vaccine for children/adolescents (ages 5-17).

What participants receive:
✅ Study-related care
👩‍⚕️ Close monitoring throughout the study
🤝 Access to research staff
💰 Compensation for qualified participants
📩 Contact us to learn more about eligibility.

04/13/2026

📣 VCRG is Now Enrolling: Teen Type 2 Diabetes GLP-1 Study
Is your teenager living with Type 2 Diabetes and currently prescribed medication? They may qualify for a clinical research study focused on GLP-1 for adolescents.
What participants receive:
✅ Study-related care
👩‍⚕️ Close monitoring throughout the study
🤝 Access to research staff
💰 Compensation for qualified participants
📩 Contact us to learn more about eligibility.
https://forms.office.com/pages/responsepage.aspx?id=tP5VAh-JKEKwrM-vzn34VTwsVqb2bjRElECQByA23-NUQ0VBWVY0NFhGNFhGVlNPM0FKWU4xWlpONC4u&route=shorturl

Harvard study finds teens who swap 30 minutes of sitting for exercise or extra sleep reduce insulin resistance by 15%, lowering diabetes risk.

04/06/2026

🚨 VCRG is now enrolling for the COPD Study!

You may qualify if you are:
✅ Ages 40–80
✅ Current or former smokers/vapers

💰 Compensation available for qualified participants
📍 Victoria Clinical Research Group

📩 Message us today to learn more or apply now:
COPD Studies—Victoria Clinical Research Group – Fill out form
"https://forms.office.com/r/iFRseUxDRh"

03/27/2026

VCRG is now enrolling for the MMRV study! 🩺
(Counts toward the school vaccine requirements.)

📢 Contact us today to enroll!
👧👦 Ages: Children aged 4 up to 6 years and 364 days
✔️ Must have received the first dose of a Varicella vaccine
✔️ Must have received the first dose of an MMR vaccine
📅 Vaccines must have been given between 12 and 24 months of age
🎁 Compensation available for qualified participants
📩 Message us today to learn more!

Measles, also called rubeola, is caused by a virus that spreads easily through the air and settles on surfaces. Symptoms, which show up about one to two week...

03/02/2026

🩺 See if your teen qualifies for our Type 2 Diabetes GLP-1 Study

If your teen has Type 2 Diabetes and is currently taking medication, they may be eligible to participate in a clinical study evaluating GLP-1 treatments.
✔️ No insurance required
✔️ Study-related care at no cost
✔️ Compensation may be available

💬 Message us today to check eligibility and learn more.

Chicago researchers find nearly 1 in 3 U.S. teens has prediabetes or Type 2 diabetes, with waist-to-height ratio a key predictor.

02/23/2026

📢 Contact us today to enroll!

👧👦 Ages: Children aged 4 up to 6 years and 364 days

✔️ Must have received the first dose of a Varicella vaccine
✔️ Must have received the first dose of an MMR vaccine
📅 Vaccines must have been given between 12 and 24 months of age

🎁 Compensation available for qualified participants

📩 Message us today to learn more!